TNF and neoplasm: Consistent with this theory, in a TRAF−/− melanoma mouse model, tumor cells redirected the TNF signaling pathway to favor RIPK1-dependent necroptosis, enhance tumor eradication, and show a better response to anti-PD-1 therapy than the control group [17].